Little Remedies Infant Fever + Pain Reliever
January 8th, 2021
In November 2020, a class-action lawsuit was filed against Prestige Consumer Healthcare for allegedly misleadingly marketing that Little Remedies Infant
January 8th, 2021
In November 2020, a class-action lawsuit was filed against Prestige Consumer Healthcare for allegedly misleadingly marketing that Little Remedies Infant
November 5th, 2020
In August 2020, a class-action lawsuit was filed against Perrigo Company and Walmart for allegedly misleadingly marketing that Equate Infant’s
November 3rd, 2020
In September 2020, a class-action lawsuit was filed against Dollar General for allegedly misleading consumers by marketing its DG™ brand
October 7th, 2020
In September 2020, a class-action lawsuit was filed against Target for allegedly misleadingly marketing Up & Up™ Infants’ Acetaminophen Fever
August 24th, 2020
In July 2020, a class-action lawsuit was filed against The Kroger Co. for allegedly misleadingly marketing Kroger® Infants’ Pain &
August 24th, 2020
August 2020: This case was transferred from state court to federal court. (Case No. 20-cv-5476, N.D. Cal.) June 2020: A
August 21st, 2020
In August 2020, a class-action lawsuit was filed against Walgreens for allegedly misleadingly marketing Infants’ Dye-Free Pain & Fever Acetaminophen
August 21st, 2020
In July 2020, a class-action lawsuit was filed against Topco Associates for allegedly misleadingly marketing TopCare® Infants’ Pain & Fever
August 21st, 2020
In June 2020, a class-action lawsuit was filed alleging that Walmart misleads consumers by marketing Equate™ Infant’s Pain & Fever
August 21st, 2020
In July 2020, a class-action lawsuit was filed against Rite Aid for allegedly misleadingly advertising its Infants’ Fever Reducer &
July 31st, 2020
May 2020: A federal judge dismissed certain claims but allowed the false advertising claims to move forward. July 2019: The
July 31st, 2020
September 2019: A federal judge dismissed certain claims but allowed the false advertising claims to move forward. November 2018: A
July 31st, 2020
April 2019: A federal judge dismissed certain claims but allowed the false advertising claims to move forward. November 2018: A
July 24th, 2020
In May 2020, a class-action lawsuit was filed against Global Institute of Stem Cell Therapy and Research for allegedly: Misleadingly
July 24th, 2020
In May 2020, a class-action lawsuit was filed against GlaxoSmithKline for allegedly falsely advertising the medication Boostrix in what has
June 30th, 2020
June 2020: A federal court judge granted final approval of the settlement agreement. December 2019: A federal judge preliminarily approved
March 31st, 2020
March 2020: The Gill case was transferred from a court in Kansas to a court in New Jersey. (Case No.
November 21st, 2019
May 2019: The appeal was dismissed for failure to prosecute because the objector did not pay the filing fees. December
October 29th, 2019
In October 2019, a class-action lawsuit was filed against Sanofi-Aventis U.S., Sanofi US Services, Chattem, Inc., and Boehringer Ingelheim Pharmaceuticals
October 22nd, 2019
In October 2019, a class-action lawsuit was filed against Sanofi for allegedly misleadingly marketing the over-the-counter heartburn medication Zantac as